Pharmacokinetic Rationale for Chemotherapeutic Drugs Combined with Intra-Arterial Degradable Starch Microspheres (Spherex®)
- 1 September 1996
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 31 (3) , 231-240
- https://doi.org/10.2165/00003088-199631030-00006
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The effect of different dose levels of degradable starch microspheres (Spherex®) on the distribution of a cytotoxic drug after regional administration to tumour-bearing ratsEuropean Journal Of Cancer, 1995
- Chemo-Occlusion for the Treatment of Liver CancerClinical Pharmacokinetics, 1994
- Hepatic Intra-Arterial Administration of Doxorubicin and Degradable Starch Microspheres: A pharmacokinetic study in the ratActa Oncologica, 1994
- Reductive Activation of Mitomycin C: A Delicate BalanceJNCI Journal of the National Cancer Institute, 1992
- Regional Chemotherapy for Colorectal Hepatic Metastases Using Degradable Starch MicrospheresActa Oncologica, 1991
- Enhanced Effect of Adriamycin on a Rat Liver Adenocarcinoma After Hepatic Artery Injection with Degradable Starch MicrospheresSelective Cancer Therapeutics, 1990
- Clinical Pharmacokinetics of DoxorubicinClinical Pharmacokinetics, 1988
- Arterial Drug Infusion: Pharmacokinetic Problems and PitfallsJNCI Journal of the National Cancer Institute, 1988
- Intra-arterial infusion of doxorubicin with degradable starch microspheres. Improvement of hepatic tumor drug uptakeArchives of Surgery, 1986
- A critical evaluation of the principles governing the advantages of intra-arterial infusionsJournal of Pharmacokinetics and Biopharmaceutics, 1974